Clinical Trial Update: Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating liposomal doxorubicin in combination with trastuzumab for women with advanced breast cancer has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED